Evaluation of HER2-targeted Therapy for Gastric Cancer and Establishment and Verification of Monitoring System
Clinical trial NCT05165602 · UNKNOWN
Trial details
- NCT number
- NCT05165602
- Sponsor
- Peking University
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-01-01
- Primary completion
- 2023-05-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.